Subgroups according to BASDAI/ASDAS category (baseline)

Por um escritor misterioso

Descrição

Subgroups according to BASDAI/ASDAS category (baseline)
Biologics Targeting, Ankylosing Spondylitis
Subgroups according to BASDAI/ASDAS category (baseline)
Subgroups according to BASDAI/ASDAS category (baseline)
Subgroups according to BASDAI/ASDAS category (baseline)
Additional Data in Active PsA
Subgroups according to BASDAI/ASDAS category (baseline)
A five-year prospective study of spinal radiographic progression and its predictors in men and women with ankylosing spondylitis, Arthritis Research & Therapy
Subgroups according to BASDAI/ASDAS category (baseline)
Extended Report Semantic Scholar
Subgroups according to BASDAI/ASDAS category (baseline)
Frontiers Prediction of radiographic progression pattern in patients with ankylosing spondylitis using group-based trajectory modeling and decision trees
Subgroups according to BASDAI/ASDAS category (baseline)
(PDF) Both Baseline Clinical Factors and Genetic Polymorphisms Influence the Development of Severe Functional Status in Ankylosing Spondylitis
Subgroups according to BASDAI/ASDAS category (baseline)
Frontiers The BASDAI Cut-Off for Disease Activity Corresponding to the ASDAS Scores in a Taiwanese Cohort of Ankylosing Spondylitis
Subgroups according to BASDAI/ASDAS category (baseline)
Baseline characteristics of ASDAS ID and ASAS PR responders and
Subgroups according to BASDAI/ASDAS category (baseline)
Genetic and Molecular Distinctions Between Axial Psoriatic Arthritis and Radiographic Axial Spondyloarthritis: Post Hoc Analyses from Four Phase 3 Clinical Trials
Subgroups according to BASDAI/ASDAS category (baseline)
Mean ASDAS and other clinical parameters in disease activity subgroups
Subgroups according to BASDAI/ASDAS category (baseline)
Inflammatory biomarkers, disease activity and spinal disease measures in patients with ankylosing spondylitis after treatment with infliximab
Subgroups according to BASDAI/ASDAS category (baseline)
Improved clinical, functional and work outcomes in spondyloarthritides during real-life adalimumab treatment in central–eastern Europe
de por adulto (o preço varia de acordo com o tamanho do grupo)